Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
20% EDTA-Solution for locating, preparing and rinsing of root canals
Dosage form and pack size
ID: Medical Device (MD)
Dosage form and pack size
ID: Medical Device (MD)
Dosage form and pack size
ID: Medical Device (MD)
*Mohammadi Z; et al. Additive and reducing effects between calcium hydroxide and current irrigation solutions; The Journal of Contemporary Dental Practice VOL; 18(3); Page 246-249; 2017
Practical tip:
You can also mix CALCIPRO with saline, CHX- or NaOCl-solution!
Dosage form and pack size
ID: Medical Device (MD)
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Dosage form and pack size
ID: Medical Device (MD)
Dosage form and pack size
ID: Medicinal product (Registration number 6030426.00.00)
HISTOLITH NaOCl 5%. Dental Solution. Active ingredient: Sodium hypochlorite. 1 ml of solution contains 52.5 mg (5.25 % m/V) sodium hypochlorite corresponding to 50 mg (5.0 % m/V) active chlorine. Additives: Sodium chloride, sodium hydroxide and purified water. Indications: For cleaning and disinfection of root canals. Contraindications: Hypersensitivity to the active substance or any other ingredients or chlorine; open apical foramen. Side Effects: On vital tissue HISTOLITH NaOCl 5% effects highly caustic. In case of an inappropriate application (e.g. pressing the solution through the apex) this, because of its tissue-dissolving properties, may cause damages on vital tissue which comes in contact with NaOCl. Mostly, but not in every case, this damages are reversible. The following side effects have been reported (frequency not known): hypersensitivity, including swelling of face or mouth, oedema, inflammation, ulceration, necrosis, ecchymosis, pain, paresthesia and anesthesia affected facial nerves. Precautions: Caution, caustic. Date of current information: 10/2014
Practical tip:
Combined with CALCINASE EDTA-solution, you also remove the smear layer!
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Klicken Sie auf den unteren Button, um den Inhalt von zu laden.
Dosage form and pack size
ID: Medical Device (MD)
Practical tip:
Combined with CALCINASE EDTA-solution, you also remove the smear layer!
Dosage form and pack size
ID: Medical Device (MD)
Practical tip:
Combined with CALCINASE EDTA-solution, you also remove the smear layer!
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Dosage form and pack size
ID: Medicinal product (Registration number 6031118.00.00)
TOXAVIT. Dental Paste. Active substances: paraformaldehyde, lidocaine hydrochloride 1 H2O and metacresol (Ph.Eur.). 1 g paste contains active ingredients: 460 mg paraformaldehyde, 370 mg lidocaine hydrochloride 1 H2O and 45 mg metacresol (Ph.Eur.). List of excipients: Eugenol, glycerol and carbon fibres. Therapeutic indications: TOXAVIT is used to devitalise dental pulp in particular cases where endodontic surgical measures (e.g. vital extirpation) are not possible. Prior to use, it should be checked whether successful treatment might be able to be achieved using other, aldehyde-free procedures (e.g. anaesthesia or bleeding control). Contraindications: Allergy to any of the active ingredients or any of the other ingredients. Undesirable effects: Uncommon: Upon extirpation of the pulp, occasional bleeding occurs at the apical site of detachment despite devitalisation. Very rare: When used on milk teeth, damage to the dental germ of the subsequent adult tooth may occur during the early stages of development (before mineralisation is complete) in extremely rare cases. Frequency not known: Following application to the exposed pulp cavity, more or less severe pulpitis-like complaints occur. These are relieved through the addition of the local anaesthetic lidocaine hydrochloride to the paste. In the event of insufficient diffusion or inadequate release of formaldehyde, vital tissue fragments can remain in the canal and cause considerable pain. If formaldehyde extravasates from the apex or the furcation area or side canals or leaking filling edges, inflammation or necrosis of periapical tissue, surrounding bone or the gums may result. Systemic effects cannot be ruled out. There are no findings on this method of application and local carcinogenicity. Local and systemic allergic reactions are possible. Date of current information: 12/2021. lege artis Pharma GmbH + Co. KG, P. O. Box 60, D-72132 Dettenhausen.
© Copyright 2021 lege artis Pharma GmbH + Co. KG | All rights reserved | Webdesign by Systeamhaus